Albemarle FCS is differentiated among many CDMOs in being positioned to supply the entire small molecule drug substance supply chain from domestic facilities. Even companies who prefer to outsource their APIs domestically often have to manage an overseas supplier of starting materials within their supply chain. This can work successfully but it can also create risk around timelines, not to mention the burden of managing a complex supply chain.
Albemarle’s offering, through our complementary South Haven, Michigan and Tyrone, Pennsylvania facilities, offers the opportunity to have an integrated domestic supply chain from registered starting materials (RSMs) through to custom APIs. So there is just one relationship to manage and you have full visibility of your project through all stages of scale-up and manufacturing.